Entrada Therapeutics, Inc. (TRDA)

12.58 +0.96 (+8.26%) USD  |  NASDAQ  |  Mar 06, 16:00
12.81 +0.23 (+1.83%) After-Hours: 20:00
More

Entrada Therapeutics EPS Diluted (5 Year Growth)

EPS Diluted (5 Year Growth) Chart

View EPS Diluted (5 Year Growth) for TRDA.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EPS Diluted (5 Year Growth) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

EPS Diluted (5 Year Growth) Range, Past 5 Years

View EPS Diluted (5 Year Growth) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Diluted (5 Year Growth) Benchmarks

View EPS Diluted (5 Year Growth) Benchmarks
Start Trial
EyePoint Plc Upgrade
Repligen Corp. Upgrade
Vertex Pharmaceuticals, Inc. Upgrade
Kodiak Sciences, Inc. Upgrade
Arcutis Biotherapeutics, Inc. Upgrade